Question 1

What is the catalog number for Human BTN2A1 Knockout A549 cell line?

Accepted Answer

The catalog number for Human BTN2A1 Knockout A549 cell line is A549KO-11008.

Question 2

What sizes are available for Human BTN2A1 Knockout A549 cell line?

Accepted Answer

Human BTN2A1 Knockout A549 cell line is available in the following size(s): 1 Vial.

Question 3

Is Human BTN2A1 Knockout A549 cell line in stock?

Accepted Answer

Human BTN2A1 Knockout A549 cell line is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Human BTN2A1 Knockout A549 cell line used for?

Accepted Answer

Engineered clonal A549 cells with BTN2A1 gene knockout, sequence confirmed.

Question 5

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 6

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 7

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Human BTN2A1 Knockout A549 cell line

Product Specifications

Frequently Asked Questions

Explore Other Products

Phthalic Acid Cyclohexyl Isobutyl Ester

TAF6L Antibody

Polystyrene A CHO

Sarcomeric Actinin Alpha 2 / ACTN2 (ACTN2/3293), CF640R conjugate, 0.1mg/mL

CF®543 Rabbit Anti-RFP

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2744), Biotin conjugate, 0.1mg/mL